MVR
Females had a greater odds of 30-day mortality after MVR compared to
males (OR 1.37, CI 1.09-1.71, p=0.006) (see table 7). However, females
had less deep sternal wound infections (OR 0.56, CI 0.29-1.05, p=0.076)
and a reduced hospital LOS (beta -1.6, CI -2.5- -0.63,
p<0.001) compared to males. There were no significant
differences between males and females for outcomes of post-operative CVA
(OR 1.00, CI 0.71-1.43, p>0.9), returning to theatre for
post-operative bleeding (OR 0.87, CI 0.70-1.08, p=0.2) and
post-operative dialysis (OR 0.88, CI 0.71-1.09, p=0.3).
Table 7: Multivariable regression analysis of outcomes following MVR,
females compared to males